The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $75.94

Today's change+0.74 +0.98%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $75.94

Today's change+0.74 +0.98%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

DaVita HealthCare Partners Inc crosses above 50-day moving average

DaVita HealthCare Partners Inc closed up Friday by (U.S.)$0.74 or 0.98% to (U.S.)$75.94 and crossing above its 50-day moving average. Over the last five days, shares have gained 3.46% and are currently 3.29% off of the 52-week high. Shares have outperformed the S&P 500 by 8.67% during the last year.

Key company metrics

  • Open(U.S.) $75.41
  • Previous close(U.S.) $75.20
  • High(U.S.) $76.00
  • Low(U.S.) $75.07
  • Bid / Ask-- / --
  • YTD % change+19.84%
  • Volume1,794,645
  • Average volume (10-day)1,120,904
  • Average volume (1-month)1,102,934
  • Average volume (3-month)1,222,534
  • 52-week range(U.S.) $61.44 to (U.S.) $78.52
  • Beta0.64
  • Trailing P/E22.58×
  • P/E 1 year forward21.13×
  • Forward PEG5.02×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.36
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.84%

Based on its net profit margin of 6.84%, DaVita HealthCare Partners Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue3,2523,1723,0433,063
Total other revenue--------
Total revenue3,2523,1723,0433,063
Gross profit925926863935
Total cost of revenue2,3272,2472,1802,128
Total operating expense2,8142,6882,6022,579
Selling / general / administrative327302287320
Research & development--------
Depreciation / amortization149146143139
Interest expense (income), net operating--------
Unusual expense (income)17000
Other operating expenses, total--------
Operating income438484441484
Interest income (expense), net non-operating-98-195-106-108
Gain (loss) on sale of assets--------
Other--------
Income before tax336282337380
Income after tax220181212244
Income tax, total117101125136
Net income184148183212
Total adjustments to net income00--0
Net income before extra. items184148183212
Minority interest-36-34-28-32
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items184148183212
Inc. avail. to common incl. extra. items184148183212
Diluted net income184148183212
Dilution adjustment----00
Diluted weighted average shares217217216215
Diluted EPS excluding extraordinary itemsvalue per share0.850.680.850.99
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.900.680.850.99